Candice Hinds, Sloan Fellow ’23, Healthcare Grad discusses her Sloan School experience.
Cell and gene therapies represent an exciting and complex new treatment type, with the potential to treat a vast range of indications.
Data management practices used to evaluate pandemic data and the deleterious effect of antiquated and varied state reporting methods.
Gaye Bok, an MIT Sloan alum, heads up the Mass General Brigham’s (MGB) $30M AI and Digital Innovation Venture Fund (AIDIF).
MIT Sloan Alum Reflects on the Effect of Healthcare Lab on Her Career
Discussion of the October 2022 HSI Convening